NCD Risk Factor Collaboration (NCD-RisC) (Kim Overvad, Marzieh Katibeh;members 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants ', Lancet, vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 The Lancet LANCET r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname NCD Risk Factor Collaboration (NCD-RisC) & O'Neill, T W 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants ', Lancet (London, England), vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante The Lancet 398 (2021) 10304 The Lancet, 398(10304), 957-980 The Lancet HIV, 398(10304), 957. Lancet Publishing Group Zaguán. Repositorio Digital de la Universidad de Zaragoza Web of Science Repositório Institucional da UNESP Universidade Estadual Paulista (UNESP) instacron:UNESP The Lancet, Elsevier, 2021, 398 (10304), pp.957-980. ⟨10.1016/S0140-6736(21)01330-1⟩ The Lancet Digital Health The Lancet Digital Health, Elsevier, 2021, 398 (10304), pp.957-980. ⟨10.1016/s0140-6736(21)01330-1⟩ NCD Risk Factor Collaboration (NCD-RisC) 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants ', The Lancet, vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 The Lancet, 398(10304), 957-980. Elsevier Ltd. The Lancet, 2021, 398 (10304), pp.957-980. ⟨10.1016/S0140-6736(21)01330-1⟩ Zhou, B, Carrillo-Larco, R M, Danaei, G, Riley, L M, Paciorek, C J, Stevens, G A, Gregg, E W, Bennett, J E, Solomon, B, Singleton, R K, Sophiea, M K, Iurilli, M LC, Lhoste, V PF, Cowan, M J, Savin, S, Woodward, M, Balanova, Y, Cifkova, R, Damasceno, A, Elliott, P, Farzadfar, F, Afzal, S, Allin, K, Andersen, L B, Bjerregaard, P, Bojesen, S E, Christensen, K, Dantoft, T M, Eliasen, M, Eriksen, L, Frikke-Schmidt, R, Giwercman, A, Halkjær, J, Jørgensen, T, Kristensen, P L, Lind, L, Linneberg, A, Mårild, S B, Møllehave, L T, Nguyen, Q V, Nordestgaard, B G, Overvad, K, Schnohr, P, Sobngwi, E, Sørensen, T IA, Tjønneland, A, Toft, U, Tolstrup, J S, Wang, Y W, Yang, Y & NCD Risk Factor Collaboration (NCD-RisC) 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants ', The Lancet, vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 The Lancet, 398(10304), 957-980. Elsevier Limited NCD Risk Factor Collaboration (NCD-RisC) 2021, ' Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 : a pooled analysis of 1201 population-representative studies with 104 million participants ', Lancet, vol. 398, no. 10304, pp. 957-980 . https://doi.org/10.1016/S0140-6736(21)01330-1 The lancet, 398(10304):957-980 The Lancet, 398(10304), 957-980. ELSEVIER SCIENCE INC
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Goodman, S G, Aylward, P E, Szarek, M, Chumburidze, V, Bhatt, D L, Bittner, V A, Diaz, R, Edelberg, J M, Hanotin, C, Harrington, R A, Jukema, J W, Kedev, S, Letierce, A, Moryusef, A, Pordy, R, Lopez, G A R, Roe, M T, Viigimaa, M, White, H D, Zeiher, A M, Steg, P G, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery ', Journal of the American College of Cardiology, vol. 74, no. 9, pp. 1177-1186 . https://doi.org/10.1016/j.jacc.2019.07.015 Journal of the American College of Cardiology, 74(9), 1177-1186. ELSEVIER SCIENCE INC
Circulation: Cardiovascular Quality and Outcomes, 12(11). LIPPINCOTT WILLIAMS & WILKINS Circulation : cardiovascular quality and outcomes Circulation-Cardiovascular Quality and Outcomes r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Circulation-cardiovascular Quality And Outcomes, 12(11). Lippincott Williams & Wilkins Szarek, M, Steg, P G, DiCenso, D, Bhatt, D L, Bittner, V A, Budaj, A, Diaz, R, Goodman, S G, Gotcheva, N N, Jukema, J W, Pordy, R, Roe, M T, Sourdille, T, White, H D, Xavier, D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial ', Circulation: Cardiovascular Quality and Outcomes, vol. 12, no. 11, e005858 . https://doi.org/10.1161/CIRCOUTCOMES.119.005858